4//SEC Filing
Kaufmann Gunnar F. 4
Accession 0001209191-22-043738
CIK 0001260990other
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 6:21 PM ET
Size
7.8 KB
Accession
0001209191-22-043738
Insider Transaction Report
Form 4
Kaufmann Gunnar F.
Chief Scientific Officer
Transactions
- Award
Common Stock
2022-07-28+43,125→ 72,992 total - Award
Stock Option
2022-07-28+28,750→ 28,750 totalExercise: $1.04Exp: 2032-07-28→ Common Stock (28,750 underlying)
Footnotes (2)
- [F1]Represents an award of restricted stock units (RSUs). Each RSU represents the right to receive one share of the Issuer's common stock upon vesting. One half of the RSUs vest on July 3, 2023, and one half of the RSUs vest on January 3, 2024, subject to the Reporting Person's continued employment or service with the Issuer on each such date. All of the RSUs vest in the event of a Change in Control (as defined in the Issuer's 2019 Incentive Award Plan).
- [F2]One half of the shares subject to the stock options vest on July 3, 2023 and one half of the shares subject to the stock options vest on January 3, 2024, subject to the Reporting Person's continued employment or service with the Issuer on each such date. All of the shares subject to the stock options vest in the event of a Change in Control (as defined in the Issuer's 2019 Incentive Award Plan).
Documents
Issuer
Oncternal Therapeutics, Inc.
CIK 0001260990
Entity typeother
Related Parties
1- filerCIK 0001786754
Filing Metadata
- Form type
- 4
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 6:21 PM ET
- Size
- 7.8 KB